Retrospective Evaluation of Mycoplasma genitalium Prevalence and Macrolide Resistance in a Study Cohort of Pregnant Women in Birmingham, AL, From 1997 to 2001.
Journal
Sexually transmitted diseases
ISSN: 1537-4521
Titre abrégé: Sex Transm Dis
Pays: United States
ID NLM: 7705941
Informations de publication
Date de publication:
01 10 2023
01 10 2023
Historique:
pmc-release:
01
10
2024
medline:
14
9
2023
pubmed:
11
7
2023
entrez:
11
7
2023
Statut:
ppublish
Résumé
In a prospective study conducted in 2020 to 2021, macrolide resistance-associated mutations were found in 41% of pregnant persons in Birmingham, AL, with Mycoplasma genitalium detected. We retrospectively evaluated M. genitalium in 203 pregnant persons participating in a study conducted in 1997 to 2001 in Birmingham and adjacent areas and found a prevalence of 11% (95% confidence interval, 6.9%-15.7%), but no macrolide resistance-associated mutations.
Identifiants
pubmed: 37432978
doi: 10.1097/OLQ.0000000000001843
pii: 00007435-990000000-00221
pmc: PMC10527314
mid: NIHMS1912810
doi:
Substances chimiques
Anti-Bacterial Agents
0
Macrolides
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
642-644Subventions
Organisme : NIAID NIH HHS
ID : K24 AI125685
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI113212
Pays : United States
Informations de copyright
Copyright © 2023 American Sexually Transmitted Diseases Association. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of Interest and Sources of Funding: W.M.G. reports having previously received honoraria as a speaker for Roche. B.V.D.P. reports receiving funding for research and honoraria for participation on advisory boards from Roche.
Références
Clin Infect Dis. 2008 Dec 15;47(12):1546-53
pubmed: 18990060
Clin Infect Dis. 2014 Jul 1;59(1):24-30
pubmed: 24729494
Lancet Infect Dis. 2021 Jan;21(1):107-115
pubmed: 32717205
Diagn Microbiol Infect Dis. 2018 Jun;91(2):123-125
pubmed: 29510884
Clin Infect Dis. 2015 Nov 1;61(9):1389-99
pubmed: 26240201
Sex Transm Infect. 2018 Sep;94(6):411-413
pubmed: 29599387
MMWR Recomm Rep. 2021 Jul 23;70(4):1-187
pubmed: 34292926
Sex Transm Infect. 2009 Oct;85(6):436-7
pubmed: 19587392
Infect Dis Obstet Gynecol. 2016;2016:4513089
pubmed: 27212873
Clin Infect Dis. 2015 Aug 1;61(3):418-26
pubmed: 25900174
Can Fam Physician. 2016 Feb;62(2):e96-101
pubmed: 27331225
Am J Perinatol. 2016 Mar;33(4):401-8
pubmed: 26479170
Clin Microbiol Rev. 2011 Jul;24(3):498-514
pubmed: 21734246
MMWR Surveill Summ. 2016 Jul 15;65(7):1-19
pubmed: 27414503
J Clin Microbiol. 2021 Oct 19;59(11):e0081921
pubmed: 34406799
Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3463-E3470
pubmed: 29581252
BMJ Open. 2021 Jun 14;11(6):e050475
pubmed: 34127494
N Engl J Med. 2004 Jul 8;351(2):154-8
pubmed: 15247355
Acta Obstet Gynecol Scand. 2004 May;83(5):455-60
pubmed: 15059158
Clin Infect Dis. 2013 Apr;56(7):934-42
pubmed: 23223595
Sex Transm Dis. 2019 Jan;46(1):18-24
pubmed: 29979336
Am J Public Health. 2007 Jun;97(6):1118-25
pubmed: 17463380
Int J Gynaecol Obstet. 2023 Jan;160(1):341-344
pubmed: 36074058
Clin Infect Dis. 2020 Dec 17;71(10):e624-e632
pubmed: 32185385
J Clin Microbiol. 2016 Sep;54(9):2278-83
pubmed: 27307460
Clin Infect Dis. 2018 Feb 10;66(5):796-798
pubmed: 29028993
Sex Transm Dis. 2019 Oct;46(10):676-682
pubmed: 31356530